Navigation Links
Alquest Announced as MedNet Solutions' First iMedNet CRO Partner
Date:10/18/2011

MINNETONKA, Minn., Oct. 18, 2011 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, and Alquest LLC, a CRO specializing in medical devices, in vitro diagnostics (IVDs), biologics and combination products, are pleased to jointly announce that Alquest has become the first organization to join the iMedNet™ CRO Partner Program.  Introduced last month by MedNet Solutions, the iMedNet CRO Partner Program helps Clinical Research Organizations (CROs) improve research efficiency, expand their service offerings, decrease internal costs and win more business.

"We're delighted to be the first iMedNet CRO Partner with MedNet Solutions," stated Linda Alexander, Chief Executive Officer of Alquest.  "Their new iMedNet EDC solution builds on the success of their proven ENLIGHTEN® software and brings eClinical capabilities to a whole new level.  I'm excited to show this to our clients and provide them with this comprehensive, state-of-the-art solution."

"iMedNet provides us with flexible, easy-to-use tools to reduce our database development timelines and effectively meet our clients' needs," noted Ann Quinlan-Smith, President of Alquest.  "iMedNet is an outstanding EDC solution for study sites as well, with simple screens and easy, yet complete navigation."

"We are extremely happy to have Alquest as our first iMedNet CRO Partner organization," commented John M. (Rob) Robertson, President and CEO of MedNet Solutions.  "Their long, proven track record, sterling reputation and strong focus on customer service are exactly what we are looking for in our CRO partners.  Alquest is just the type of quality organization that many prospective iMedNet customers are looking for to build and manage their studies."  

Please contact MedNet Solutions for more information on the iMedNet CRO Partner Program.

About MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in electronic data capture (EDC) and clinical study management systems designed for the global life sciences market. Applying critical insight, proven technology and unwavering support, MedNet delivers powerful, flexible and easy-to-use web-based eClinical solutions that effectively support clinical studies, registries and investigator initiated trials. Since 2000, MedNet has successfully supported leading pharmaceutical, medical device, biotechnology, and contract research organizations on clinical research conducted around the world. MedNet delivers a superior customer experience from beginning to end.  For more information, please visit www.mednetstudy.com.

About Alquest LLC – a NAMSA Company

Alquest LLC is a NAMSA company.  Founded 17 years ago, Alquest supports medical device manufacturers in the areas of regulatory strategy and submissions; clinical trial design and trial conduct; quality systems; and product safety, biocompatibility and sterilization.  NAMSA is the world's leading medical device-focused contract research organization specialized in safety evaluations. For more information, see www.alquest.com and www.namsa.com

Contact Information:
Dirk H. Nelson
Director of Marketing
MedNet Solutions
110 Cheshire Lane, Suite 300
Minnetonka, MN  55305
USA
(763) 258-2735

Linda S. Alexander
Chief Executive Officer/Founder
Alquest LLC – a NAMSA Company
4050 Olson Memorial Highway, Suite 350
Minneapolis, MN  55422
USA
(763) 287-3830


'/>"/>
SOURCE MedNet Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
2. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
3. Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimers Disease Announced
4. PRoFESS(R) Results Announced at XVII European Stroke Conference
5. Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules
6. Calabar AB Today Announced New Financing for Continuation of the Phase II Program in Patients With Dry Mouth
7. 2008 Human Research Protection Award Recipients Announced
8. Results From Drug Trials and New Risk Factors Announced at International Alzheimers Conference
9. Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced
10. Biotel Announced Profitable First Quarter Ended September 30, 2009
11. New Executive Leadership and CEO Announced for BiPar Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... 6, 2017  Medical professionals are expected ... while treating their patients. Medical simulations offer ... involving patients. Simulation provides a safe method ... out procedures, refine techniques and build confidence, ... new technology, such as augmented reality, will ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a ... created a vibrant charitable donation program -- "Color ... support congenital heart defect research by The Children,s ... and the general public are encouraged to download ... submit the completed artwork to the gallery on ...
Breaking Medicine Technology:
(Date:9/20/2017)... Houston, Texas (PRWEB) , ... September 20, 2017 ... ... leader in the Orthodontics and Clear Aligner clinical and commercial support services market) ... School of Dentistry (PGSD) in Sydney, Australia. , The PGSD is the ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short time since going ... receiving positive feedback from customers trying the product for the first time, and others ... was developed by neurosurgeon Shawn Moore, MD, for everyone from athletes at risk from ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Americans at risk of price gouging for their prescription drugs, according to a ... “Because Medicare isn’t negotiating on our behalf, there’s no consistency in drug pricing ...
(Date:9/20/2017)... ... , ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION”: A ... is the creation of published author, Bill Miller. Bill Miller has a ... more than a decade of addiction to prescription drugs. He has a ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Psalms of Humidity”: is a fascinating depiction of ... the readers one step closer to God. “Psalms of Humidity” is the creation of ... have been made within his life are the very same things that have shaped ...
Breaking Medicine News(10 mins):